Form 4: IQVIA Executive Ronald E. Bruehlman Reports Stock Transactions

Ronald E. Bruehlman, EVP & Chief Financial Officer of IQVIA Holdings Inc., reported the acquisition of 6,286 shares and the disposal of 2,201 shares of common stock, along with the acquisition of 31,603 stock appreciation rights.

Summary

• Ronald E. Bruehlman, an executive at IQVIA Holdings Inc., has reported several transactions involving the company's stock.
• On January 28, 2025, Mr. Bruehlman acquired 6,286 shares of common stock as part of a performance-based restricted stock unit award.
• He also disposed of 2,201 shares of common stock at a price of $203.43 per share.
• Additionally, Mr. Bruehlman acquired 31,603 stock appreciation rights, which vest in three annual installments starting January 28, 2026.
• Following these transactions, Mr. Bruehlman directly owns 35,476 shares of common stock and indirectly owns 11,893 shares through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares due to performance targets being met is a positive sign, while the disposal of shares is a common occurrence and not necessarily negative. The stock appreciation rights are a standard incentive.

Positives

• The acquisition of 6,286 shares indicates that performance targets were met, which is a positive sign for the company's performance.
• The vesting of stock appreciation rights provides an incentive for the executive to continue to perform well.

Negatives

• The disposal of 2,201 shares, while potentially for tax purposes, could be interpreted as a slight negative signal.

Risks

• Executive stock transactions can sometimes be misinterpreted by the market, potentially leading to short-term price volatility.
• The vesting of stock appreciation rights is subject to the executive remaining with the company.

Future Outlook

The stock appreciation rights vest in three annual installments beginning on January 28, 2026, which could lead to further stock transactions in the future.

Management Comments

• The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often tied to performance and compensation plans. This filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors, where IQVIA operates.
• The vesting schedule of the stock appreciation rights is typical, with a three-year vesting period.
• The price at which the shares were disposed of is consistent with the market price of IQVIA stock at the time of the transaction.
• Companies like Oracle, Accenture, and Cognizant also use stock-based compensation as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view the acquisition of shares as a positive sign of the company's performance.
• The vesting of stock appreciation rights aligns executive interests with shareholder value.

Next Steps

• The stock appreciation rights will vest in three annual installments starting January 28, 2026.
• Further Form 4 filings may be expected as the stock appreciation rights vest and are exercised.

Key Dates

Keywords

IQVIA, stock transactions, insider trading, stock appreciation rights, performance-based awards, executive compensation, Form 4, Ronald E. Bruehlman